Nai-jian Ge
Shanghai, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Machine Learning-Guided Personalized Immunochemotherapy Strategies in Intrahepatic Cholangiocarcinoma.
Journal: JHEP reports : innovation in hepatology
Published: April 21, 2026
Portal vein embolization for arterio-portal shunt closure in hepatocellular carcinoma to facilitate selective internal radiation therapy.
Journal: World journal of radiology
Published: April 07, 2026
A Dynamic Prognostic and Adaptive Treatment Framework for Advanced Biliary Tract Cancer.
Journal: JHEP reports : innovation in hepatology
Published: February 16, 2026
Coil-assisted N-butyl cyanoacrylate embolization vs covered stent implantation for delayed hemorrhage in hepatobiliary and pancreatic surgery.
Journal: World journal of gastrointestinal surgery
Published: May 06, 2025
Radiation-emitting metallic stent for unresectable Bismuth type III or IV perihilar cholangiocarcinoma: a multicenter randomized trial.
Journal: International journal of surgery (London, England)
Published: February 28, 2024
Immune checkpoint inhibitors and anti-vascular endothelial growth factor antibody/tyrosine kinase inhibitors with or without transarterial chemoembolization as first-line treatment for advanced hepatocellular carcinoma (CHANCE2201): a target trial emulation study.
Journal: EClinicalMedicine
Published: January 10, 2024
Portal vein embolization for closure of marked arterioportal shunt of hepatocellular carcinoma to enable radioembolization: A case report.
Journal: World journal of gastrointestinal surgery
Published: August 17, 2023
Real-world efficacy and safety of TACE plus camrelizumab and apatinib in patients with HCC (CHANCE2211): a propensity score matching study.
Journal: European radiology
Published: October 05, 2022
Endovascular treatment of delayed arterial hemorrhage after radical operation for hilar cholangiocarcinoma.
Journal: Hepatobiliary & pancreatic diseases international : HBPD INT
Published: July 30, 2022
Transarterial chemoembolization with PD-(L)1 inhibitors plus molecular targeted therapies for hepatocellular carcinoma (CHANCE001).
Journal: Signal transduction and targeted therapy
Published: June 14, 2022
Recurrent undifferentiated embryonal sarcoma of the liver in adult patient treated by pembrolizumab: A case report.
Journal: World journal of clinical cases
Published: September 20, 2020
Genetic Variants in ASCT2 Gene are Associated with the Prognosis of Transarterial Chemoembolisation-Treated Early- Stage Hepatocelluar Carcinoma.
Journal: Asian Pacific journal of cancer prevention : APJCP
Published: May 20, 2015
Last Updated: 09/26/2026